Results 201 to 210 of about 29,411 (265)

Functional deficiency of circadian regulator PER2 enhances breast cancer susceptibility and progression with immunosuppression. [PDF]

Oncogene
Duan Y, Alexandrou AT, Huang J, Zhang HS, Zhang H, Zhang X, Hao D, Berg JI, Fan M, Wang Y, Fu L, Sun L, Li JJ.   +12 more
europepmc   +1 more source

TBL1XR1 mutations promoted tumor progression in diffuse large B-cell lymphoma through impairing nature killer cytotoxicity via the MYC-CD47/PD-L1 axis. [PDF]

Mol Cancer
Zhu Y, Shen YG, Tang W, Zheng Z, Chen SY, Huang YH, Fu D, Cheng S, Xu PP, Wang L, Chen J, Ji MM, Zhao WL.   +12 more
europepmc   +1 more source

Erythrocytes as immunomodulators in trauma: orchestrating clearance pathways, inflammation, and organ injury. [PDF]

Front Immunol
Qian X, Chen L, Gao R, Lin Y, Wu K, Wang X, Jiang Y.   +6 more
europepmc   +1 more source

Cell-Surface Signatures and Targets of Modulated Vascular Smooth Muscle Cells in Atherosclerosis: From State Identification to Precision Intervention. [PDF]

J Cardiovasc Dev Dis
Xu Y, Wang Y, Wu H, Li P, Zhuang J, Shen Z, Lu Z, Zhang C, Chen Y.   +8 more
europepmc   +1 more source

Expression of Immune Checkpoint-Associated Proteins for CD24, Siglec-10, CD47, and SIRPα in Breast Phyllodes Tumor. [PDF]

Int J Mol Sci
Shin E, Koo JS.
europepmc   +1 more source

Hypoxia-Induced Expression of miR-424, miR-155, CD47, and PD-L1 in a Gastric Cancer Cell Line (MKN-45). [PDF]

Iran Biomed J
Samemaleki S, Orooji N, Kazemi T, Solgi G.   +3 more
europepmc   +1 more source

Fast-Food Component-Induced Epigenetic Modifications Modulate Immunotherapy in Metastatic Breast Cancer. [PDF]

ACS Omega
Mukherjee A, Janah P, Tripathi A, Gayen P, Sinha Roy R.   +4 more
europepmc   +1 more source

Inhibition of histone demethylase LSD1 suppresses CD47 expression and enhances efficacy of CD47 blockade in breast cancer. [PDF]

J Immunother Cancer
Jiang F, Shen Y, Li B, Henry M, Davidson N, Huang Y.   +5 more
europepmc   +1 more source

Transcriptional intermediary factor 1 gamma-based multitarget gene therapeutic strategy for triple-negative breast cancer. [PDF]

Signal Transduct Target Ther
Park H, Kim TY, Yun H, Cha A, Moon D, Yun E, Kim Y, Im SA, Lee DW, Park C, Kim HK, Lee HB, Lee J, Cho NJ, Lee EJ, Kim HS.   +15 more
europepmc   +1 more source

CD47 monoclonal antibody enhances the inhibitory effect of anti-HER2 chimeric antigen receptor macrophages on ovarian cancer. [PDF]

Oncol Lett
Qiao J, Kou Q, Qiu J.
europepmc   +1 more source